Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas

May 17, 2024 | Comments Off on Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas

Translational Lung Cancer Research 2024 April 29 [Link] Nancy Alnassar, Jonathan M J Derry, Giuseppe Luigi Banna, Dariusz C Gorecki Abstract Background: The identification of prognostic biomarkers is crucial for…

Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma

May 16, 2024 | Comments Off on Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma

Journal of Clinical Medicine 2024 April 29 [Link] Carlo Iadevaia, Vito D’Agnano, Raffaella Pagliaro, Felice Nappi, Raffaella Lucci, Simona Massa, Andrea Bianco, Fabio Perrotta Abstract Background/Objectives: Ultrasound (US) has been…

Malignant peritoneal mesothelioma presenting with bilateral hydronephrosis and renal insufficiency: a case report and literature review

May 15, 2024 | Comments Off on Malignant peritoneal mesothelioma presenting with bilateral hydronephrosis and renal insufficiency: a case report and literature review

Frontiers in Surgery 2024 April 24 [Link] Jisheng Luo, Jinhong Pan, Chuanhua Zhong, Lina Wang, Heng Zhang Abstract Introduction: Malignant peritoneal mesothelioma (MPM) is an extremely rare tumor with nonspecific…

BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma

May 14, 2024 | Comments Off on BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma

JTO Clinical and Research Reports 2024 March 29 [Link] Duo Xu, Yanyun Gao, Haitang Yang, Marc Spils, Thomas M Marti, Tereza Losmanová, Min Su, Wenxiang Wang, Qinghua Zhou, Patrick Dorn,…

Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy

May 13, 2024 | Comments Off on Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy

Scientific Data 2024 May 3 [Link] Wee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, Alistair R R Forrest, Vanessa S Fear, Catherine Forbes, Louis Boon, Anthony Bosco, Belinda B…

Aerostasis to limit air-leak following extended pleurectomy-decortication

May 10, 2024 | Comments Off on Aerostasis to limit air-leak following extended pleurectomy-decortication

European Journal of Cardio-Thoracic Surgery 2024 May 2 [Link] An-Lies Provoost, Andreas Bouckaert, Cedric Vanluyten, Annalisa Barbarossa, Kristiaan Nackaerts, Birgit Weynand, Johan Coolen, Sofian Bouneb, Olivia Theisen-Lauk, Isabelle Opitz, Philippe…

Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

May 9, 2024 | Comments Off on Pleural mesothelioma from fluoro-edenite exposure: PACAP and PAC1 receptor. A preliminary report

European Journal of Histochemistry 2024 May 2 [Link] Claudia Lombardo, Grazia Maugeri, Agata Grazia D’Amico, Giuseppe Broggi, Rosario Caltabiano, Veronica Filetti, Serena Matera, Velia D’Agata, Carla Loreto Abstract Pleural mesothelioma…

Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy

May 8, 2024 | Comments Off on Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy

Cancers 2024 April 20 [Link] Laura V Klotz, Julia Zimmermann, Karolina Müller, Julia Kovács, Mohamed Hassan, Michael Koller, Severin Schmid, Gunnar Huppertz, Till Markowiak, Bernward Passlick, Hans-Stefan Hofmann, Hauke Winter,…

Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis

May 7, 2024 | Comments Off on Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis

Critical Reviews in Oncology and Hematology 2024 April 26 [Link] Wei Zhuang, Lihui Liu, Boyang Sun, Hua Bai, Zhijie Wang, Jianchun Duan, Rui Wan, Zixiao Ma, Jia Zhong, Jie Wang…

Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights

May 6, 2024 | Comments Off on Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights

Open Respiratory Archives 2024 April 5 [Link] Rafael López-Castro, Álvaro Fuentes-Martín, Andrea Medina Del Valle, Tania García Peña, José Soro García, Leticia López González, Ángel Cilleruelo Ramos Abstract MPM stands…

Categories